What is NDC 51672-4228?

51672-4228 is the product NDC for Rivaroxaban, Rivaroxaban 2.5 mg/1 tablet, coated, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Sun Pharmaceutical Industries, Inc., NDC labeler code 51672. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rivaroxaban?

32 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rivaroxaban NDC 51672-4228 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51672-4228Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51672-4228Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51672-4228-4	5167242280451672422804	60 TABLET, COATED in 1 BOTTLE (51672-4228-4)Marketed from Oct 15, 2025
51672-4228-9	5167242280951672422809	180 TABLET, COATED in 1 BOTTLE (51672-4228-9)Marketed from Oct 15, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rivaroxaban
Generic name (nonproprietary): rivaroxaban
Active ingredients: Rivaroxaban — 2.5 mg/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.NDC labeler code 51672
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208557
Marketing start: Oct 15, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Factor Xa Inhibitors (Mechanism)
Identifiers: Product ID 51672-4228_52d1407e-403f-49ef-e063-6294a90ab543SPL ID 52d1407e-403f-49ef-e063-6294a90ab543SPL set ID 925a9a11-ae5b-405c-96d2-b1be4b85bf71RxCUI 2059015UNII 9NDF7JZ4M3UPC 0351672422844
Pharmacologic class: Factor Xa Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672422804 followed by a unit qualifier and the quantity

Package 51672-4228-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Rivaroxaban is a factor Xa inhibitor indicated: to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) ( 1.7 ) to reduce the risk of major thrombotic vascular events in patients with peripheral artery disease (PAD), including patients after recent lower extremity revascularization due to symptomatic PAD ( 1.8 ) 1.7 Reduction of Risk of Major Cardiovascular Events in Patients with Coronary Artery Disease (CAD) Rivaroxaban tablets, in combination with aspirin, are indicated to reduce the risk of major cardiovascular events (cardiovascular death, myocardial infarction, and stroke) in adult patients with coronary artery disease. 1.8 Reduction of Risk of …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51672-4228

What is NDC 51672-4228?: 51672-4228 is the product NDC for Rivaroxaban, Rivaroxaban 2.5 mg/1 tablet, coated, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rivaroxaban.
What is the active ingredient?: Rivaroxaban.
Who is the labeler?: Sun Pharmaceutical Industries, Inc., NDC labeler code 51672. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rivaroxaban?: 32 other product NDCs are listed under this name. See all Rivaroxaban NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rivaroxaban NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Lifestar Pharma LLC	70756-006	70756-0006-1270756-0006-6070756-0006-81+1 more
Rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Micro Labs Limited	42571-345	42571-0345-0542571-0345-3042571-0345-60
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	NorthStar RxLLC	72603-890	72603-0890-0172603-0890-02
rivaroxaban	Rivaroxaban 10 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0540	55488-0540-01
rivaroxaban	Rivaroxaban 15 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0541	55488-0541-01
rivaroxaban	Rivaroxaban 20 mg/1	Tablet, Film coatedOral	Changzhou Pharmaceutical Factory	55488-0542	55488-0542-01
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	XLCare Pharmaceuticals, Inc.	72865-321	72865-0321-1872865-0321-60
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-416	72205-0416-0272205-0416-0372205-0416-04+1 more
rivaroxaban	Rivaroxaban 2.5 mg/1	TabletOral	Florida Pharmaceutical Products, LLC	71921-405	71921-0405-0671921-0405-21
Rivaroxaban	Rivaroxaban 2.5 mg/1	Tablet, Film coatedOral	Indoco Remedies Limited	14445-147	14445-0147-1014445-0147-1814445-0147-60

All 33 Rivaroxaban NDCs